Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
Abstract Ovarian cancer is the most malignant gynecologic cancer among women worldwide. Cryptotanshinone (CT), isolated from Salvia miltiorrhiza Bunge, has been identified as a potential therapeutic agent in treating several malignant tumors, but the molecular mechanism of CT in ovarian cancer still...
Saved in:
| Main Authors: | Yufei Yang, Yue Cao, Lihua Chen, Fei Liu, Zihao Qi, Xi Cheng, Ziliang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-09-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.1691 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications
by: Zheng Z, et al.
Published: (2024-12-01) -
Effect of Co-Solvents, Modified Starch and Physical Parameters on the Solubility and Release Rate of Cryptotanshinone from Alcohologels
by: Justyna Kobryń, et al.
Published: (2024-12-01) -
A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1/2/Iron/PARP/calcium pathway
by: Ying Hou, et al.
Published: (2025-02-01) -
Effects of cryptotanshinone in treatment of polycystic ovary syndrome in rats: a systematic review and meta-analysis
by: Pingping Su, et al.
Published: (2025-05-01) -
SIRT3 mediates CPT2 delactylation to enhance mitochondrial function and proliferation in goat granulosa cells
by: Shuaifei Song, et al.
Published: (2025-07-01)